Situation of India in the COVID-19 Pandemic: India's Initial Pandemic Experience.
COVID-19
India
case study
coronavirus
economic impact
epidemiology
global health
health systems
non-pharmaceutical interventions
social disruption
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
02 12 2020
02 12 2020
Historique:
received:
25
10
2020
revised:
22
11
2020
accepted:
24
11
2020
entrez:
5
12
2020
pubmed:
6
12
2020
medline:
18
12
2020
Statut:
epublish
Résumé
In this article, we investigate the impact of COVID-19 through screening and surveillance methods adopted in India, as well as the potential health system, social, political, and economic consequences. The research was done in a chronological manner, and data was collected between 30 January 2020 till 12 June 2020. Initial containment measures, including point of entry screenings and testing protocols, appeared insufficient. However, testing capacity was gradually expanded after the commencement of a nation-wide lockdown. Modeling predictions have shown varying results on the emergence of cases depending on the infectiousness of asymptomatic individuals, with a peak predicted in mid-July having over two million cases. The country also faces risks of the economic plunge by losing approximately 4% of its gross domestic product, due to containment measures and reduction in goods importation. The low public health expenditure combined with a lack of infrastructure and low fiscal response implies several challenges to scale up the COVID-19 response and management. Therefore, an emergency preparedness and response plan is essential to integrate into the health system of India.
Identifiants
pubmed: 33276678
pii: ijerph17238994
doi: 10.3390/ijerph17238994
pmc: PMC7730885
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Front Public Health. 2020 Jul 03;8:347
pubmed: 32719765
J Ayurveda Integr Med. 2018 Apr - Jun;9(2):143-150
pubmed: 29858128
JMIR Public Health Surveill. 2020 May 7;6(2):e19368
pubmed: 32365045
Lancet Glob Health. 2020 Jun;8(6):e754-e755
pubmed: 32278364
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Public Health. 2018 Jun;159:4-7
pubmed: 29673888
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):190-199
pubmed: 32362645
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):147-159
pubmed: 32362642
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
Lancet. 2020 Feb 29;395(10225):675
pubmed: 32113494
PLoS One. 2016 Jul 08;11(7):e0158332
pubmed: 27391322
J Perinatol. 2016 Dec;36(s3):S9-S12
pubmed: 27924110
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046816
BMJ. 2020 May 29;369:m2170
pubmed: 32471832
JMIR Public Health Surveill. 2020 Jun 1;6(2):e19927
pubmed: 32452819
Med J Armed Forces India. 2020 Apr;76(2):147-155
pubmed: 32292232
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127
pubmed: 32496241
F1000Res. 2020 Apr 1;9:225
pubmed: 32566139
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):177-183
pubmed: 32362643